Search clinical trials for: vaso-occlusive crises

Total 497 results

Eisai Co., Ltd.

Completed

Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy

Epilepsy

Germany
GlaxoSmithKline

Terminated

Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097

Epilepsy

Spain, Australia, Russian Federation, Israel, Belgium, Hungary, France, Germany, Poland, South Africa, Ukraine, United Kingdom
George Washington University
King's College London; Duke University; World Health Organization; Transcultural...

Completed

Pilot Feasibility Study of Psychosocial Support to Improve Well-being of Adults in Humanitarian Crises in Nepal (PM+)

Depression

Nepal
Emory University
American Diabetes Association

Completed

Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic Crises

Diabetes Mellitus, Type 2

United States
Assistance Publique - Hôpitaux de Paris

Completed

Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus (LORACLOFT)

Epilepsy | Status Epilepticus

France
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID); National Institute...

Completed

Blood Flow and Pain Crises in People With Sickle Cell Disease

Sickle Cell Disease

United States
UCB Pharma

Completed

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Epilepsy

United States, Mexico, India, Brazil
University College Dublin
National Children's Research Centre; Our Lady's Children's Hospital, Crumlin

Completed

Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in Children

Pain | Sickle Cell Disease

Ireland
VA Office of Research and Development

Completed

Exposure Therapy For Veterans With PTSD And Panic Attacks

PTSD | Panic Attacks

United States
Ottawa Hospital Research Institute
The Ottawa Hospital Academic Medical Association; Canadian Anesthesiologists...

Completed

Cognitive Aids With Roles Defined (CARD) for Obstetrical Crises: A Multisite Cohort Study

Obstetrical Emergency Situations

Canada
University Hospital, Ghent
University Ghent

Completed

Epidogs International Inventory of Seizure Alert Dogs

Epilepsy

Belgium
Eisai Co., Ltd.

Completed

A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)

Refractory Partial Seizures

Japan
Centre Hospitalier Universitaire, Amiens

Unknown

Concomitant High-resolution Recording of Haemodynamic and Electrical Activities of Children With Typical or Atypical Absence Seizures (Absence)

Epilepsy

France
GlaxoSmithKline

Terminated

Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures

Epilepsy

Thailand, Korea, Republic of, Singapore, Hong Kong, Taiwan, Malaysia, Philippines
Acorda Therapeutics

Terminated

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

Epilepsy

United States
UCB BIOSCIENCES, Inc.

Completed

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures (ALEX-MT)

Epilepsy

Austria, United States, Australia, Canada, Denmark, France, Germany, Ireland, Italy, Poland, Puerto Rico, Spain, United Kingdom
UCB Pharma

Completed

Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures

Epilepsy

United States, Argentina, Australia, Belgium, Bulgaria, Colombia, Croatia, Czechia, Estonia, Georgia, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Montenegro, Poland, Romania, Russian Federation, Serbia, Sl... and more
UCB BIOSCIENCES, Inc.

Completed

Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Partial Epilepsies

United States
UCB BIOSCIENCES, Inc.

Completed

Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Epilepsy

United States
Novartis Pharmaceuticals

Completed

A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)

Gout

United States, Colombia, Russian Federation, Taiwan, Argentina, Turkey, Germany, Singapore, Spain, Hungary, Guatemala, Poland, South Africa, Slovakia, Portugal, Belgium, Czechia, United Kingdom
Sunovion

Completed

Eslicarbazepine Acetate Monotherapy Long Term Study

Epilepsy

United States, Canada, Bulgaria, Ukraine, Czechia, Serbia
UCB BIOSCIENCES, Inc.

Completed

Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures

Partial Epilepsies | Partial Onset Seizures

United States
UCB BIOSCIENCES, Inc.

Completed

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

Partial Epilepsies | Partial Onset Seizures

United States
UCB BIOSCIENCES, Inc.

Completed

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Epilepsy

United States
UCB BIOSCIENCES, Inc.
PRA Health Sciences

Terminated

Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures

Nonconvulsive Electrographic Seizures

United States
UCB Pharma

Terminated

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Epilepsy

United States, Belgium, Canada, Germany, Sweden, Czechia, Australia
UCB Pharma

Terminated

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Epilepsy

United States, France, Germany, Spain, Hungary, Italy
UCB Pharma SA

Completed

Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy

Epilepsy

United States, France, Germany, Spain
UCB Pharma

Completed

An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam

Epilepsy

Canada, United States, Australia, Belgium, Czechia, France, Germany, Hungary, Italy, Spain, Sweden
Brain Sentinel

Completed

Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients

Epilepsy | Generalized Tonic-Clonic Seizures

United States
New York State Psychiatric Institute
Shire

Completed

Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder

Oppositional Defiant Disorder | Attention Deficit Disorder | Childhood Aggression | Intermittent Explosive Disorder

United States
Aatif Husain
UCB Pharma

Completed

Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures (TRENdS)

Nonconvulsive Seizures

United States
Medical University of South Carolina
UCB Pharma

Withdrawn

Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study

Seizure, Alcohol Related

United States
Milton S. Hershey Medical Center
Takeda Pharmaceuticals North America, Inc.

Terminated

Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety

Insomnia | Panic Disorder

United States
TWi Biotechnology, Inc.

Completed

A Proof-of-Concept Study of AC-201 to Prevent Gout Flares

Gout Flares

Taiwan
Valley Anesthesiology Consultants
Phoenix Children's Hospital

Terminated

A Comprehensive Care Plan for Pediatric Patients With Vaso-Occlusive Crises

Sickle Cell Disease | Sickle Cell Crisis | Vaso-Occlusive Crises

United States
NYU Langone Health

Withdrawn

Turmeric as Treatment in Epilepsy

Epilepsy | Tuberous Sclerosis | Dravet Syndrome | Focal Seizures | Lennox-Gastaut Syndrome

United States
UCB Pharma SA

Completed

Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy

Epilepsy

Ukraine, Belgium, Germany, Hong Kong, India, South Africa, Taiwan, Sweden, Korea, Republic of, Singapore, Russian Federation, Austria, Italy, Norway, Czechia
Lundbeck LLC

Completed

Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome (LGS)

Lennox-Gastaut Syndrome
Lawson Health Research Institute

Completed

Seizures After Cardiac Surgery -- A Study With Continuous EEG Monitoring

Non-convulsive Seizures

Canada
University Health Network, Toronto

Unknown

Virtual Reality Simulation for Teaching and Assessment of Anesthesia Crisis Management

Patient Simulation

Canada
Palo Alto Health Sciences, Inc.

Completed

Using the Canary Breathing System for Panic Disorder Patients

Panic Disorder

United States
Sunovion

Withdrawn

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Epilepsy

United States
Penn State University

Terminated

Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study

Seizures
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR)

Withdrawn

Evaluating the Efficacy of Magnetic Seizure Therapy in Treatment Resistant Depression.

Depressive Disorder

Canada
West-Ward Pharmaceutical

Completed

Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures

Epilepsy

United States, Puerto Rico
University of Arizona
Centers for Disease Control and Prevention

Completed

Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors

Epileptic Seizures

United States
GlaxoSmithKline

Completed

LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures

Seizure, Absence

United States
UCB Pharma

Terminated

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide (VICTOR)

Epilepsy, Partial

Austria, Germany, Spain
UCB Pharma SA
UCB Japan Co. Ltd.

Completed

A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures

Epilepsy | Partial Onset Seizures

China, Japan

Search clinical trials for: vaso-occlusive crises

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations